Smithfield Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30K Hold
1,759
﹤0.01% 651
2025
Q1
$27K Sell
1,759
-980
-36% -$15K ﹤0.01% 656
2024
Q4
$61K Hold
2,739
﹤0.01% 530
2024
Q3
$50K Buy
2,739
+980
+56% +$17.9K ﹤0.01% 559
2024
Q2
$29K Hold
1,759
﹤0.01% 622
2024
Q1
$25K Hold
1,759
﹤0.01% 669
2023
Q4
$19K Hold
1,759
﹤0.01% 717
2023
Q3
$18K Hold
1,759
﹤0.01% 702
2023
Q2
$13K Hold
1,759
﹤0.01% 782
2023
Q1
$15K Hold
1,759
﹤0.01% 720
2022
Q4
$16K Hold
1,759
﹤0.01% 694
2022
Q3
$14K Hold
1,759
﹤0.01% 709
2022
Q2
$13K Hold
1,759
﹤0.01% 764
2022
Q1
$16K Hold
1,759
﹤0.01% 745
2021
Q4
$14K Hold
1,759
﹤0.01% 783
2021
Q3
$18K Hold
1,759
﹤0.01% 730
2021
Q2
$18K Hold
1,759
﹤0.01% 721
2021
Q1
$20K Hold
1,759
﹤0.01% 703
2020
Q4
$17K Hold
1,759
﹤0.01% 705
2020
Q3
$16K Hold
1,759
﹤0.01% 676
2020
Q2
$22K Hold
1,759
﹤0.01% 612
2020
Q1
$16K Hold
1,759
﹤0.01% 612
2019
Q4
$17K Hold
1,759
﹤0.01% 642
2019
Q3
$12K Hold
1,759
﹤0.01% 718
2019
Q2
$16K Hold
1,759
﹤0.01% 662
2019
Q1
$28K Hold
1,759
﹤0.01% 559
2018
Q4
$27K Hold
1,759
﹤0.01% 551
2018
Q3
$38K Hold
1,759
﹤0.01% 564
2018
Q2
$43K Hold
1,759
0.01% 549
2018
Q1
$30K Hold
1,759
﹤0.01% 587
2017
Q4
$33K Hold
1,759
﹤0.01% 592
2017
Q3
$31K Hold
1,759
﹤0.01% 595
2017
Q2
$58K Sell
1,759
-20
-1% -$659 0.01% 503
2017
Q1
$57K Buy
1,779
+20
+1% +$641 0.01% 499
2016
Q4
$64K Buy
1,759
+1,350
+330% +$49.1K 0.01% 469
2016
Q3
$19K Sell
409
-200
-33% -$9.29K ﹤0.01% 638
2016
Q2
$31K Hold
609
0.01% 560
2016
Q1
$33K Sell
609
-496
-45% -$26.9K 0.01% 548
2015
Q4
$73K Hold
1,105
0.02% 436
2015
Q3
$62K Sell
1,105
-1,425
-56% -$80K 0.01% 457
2015
Q2
$149K Buy
2,530
+1,186
+88% +$69.8K 0.03% 328
2015
Q1
$84K Hold
1,344
0.02% 436
2014
Q4
$77K Sell
1,344
-1,700
-56% -$97.4K 0.02% 440
2014
Q3
$164K Sell
3,044
-155
-5% -$8.35K 0.03% 337
2014
Q2
$168K Hold
3,199
0.03% 374
2014
Q1
$169K Sell
3,199
-1,580
-33% -$83.5K 0.03% 382
2013
Q4
$191K Buy
4,779
+210
+5% +$8.39K 0.04% 343
2013
Q3
$173K Buy
4,569
+4,210
+1,173% +$159K 0.04% 342
2013
Q2
$14K Buy
+359
New +$14K ﹤0.01% 611